According to officials with the Food and Drug Administration, a number of medicines are getting harder to find these days, including a commonly-used antibiotic called amoxicillin.
Europe is facing a drug shortage of antibiotics like amoxicillin, which is used to treat respiratory infections. The signs of the crisis started to show in late 2022 with countries reporting problems in sourcing certain important drugs.
For months, it has become increasingly difficult for people across Europe to find basic medicines. The European Medicines Agency says there is a shortage of 13 drugs, including those needed for leukaemia, diabetes, and the symptoms of COVID-19. Suggestions that the EU needs to consider building up a stock of 3 to 4 months’ supply of the most needed medications so that shortages can be mitigated
The Independent Community Pharmacist Association says it's concerned about the shortage of essential medications in the country. Jackie Maimin, CEO of the Independent Community Pharmacist Association, discussed the shortage with eNCA's Masego Rahlaga
Dr. Rachel Rau, Assistant Professor at Baylor College of Medicine, discuss common causes and impacts of drug shortages, as well as unique approaches to collaboration during drug development to ensure reliable access to treatment for patients, specifically with certain rare forms of leukemia and lymphoma.
Drug shortages impact everyone involved in patient care, here is a roundup of some shortages occurring around the world now...' Do you see what we see? The world is a very different place when you can't find or get access to medicines. "Now imagine..."
Guillaume Beraud MD, PhD, infectious diseases specialist at the University Hospital of Poitiers in Poitiers, France, presents the update on drug shortages situation in France. Similarly to many countries, the COVID crisis weakened an already fragile system and the number of shortages rises. However, at the occasion of this crisis, a digital tool has been put in place: e-Dispostock on which the stock of essential medicines has to be reported, and a centralized management of the stocks has been implemented. In the near future, it may help getting an exhaustive information on shortages, which would be the first step toward better management.
Marianne Jahre, professor at the BI Norwegian Business School in Oslo, Norway, presents the update on drug shortages in Norway. Jahre present updated numbers of registered shortages in Norway. While the numbers have almost doubled from 2018 to 2019, they have flattened out in 2020. Stakeholders do not agree on the definition of shortages in Norway, some only including those which have effects on patients, others also including those which are mitigated so that the patient gets what is needed
Roberto Frontini, the German delegate and former president of the European Association of Hospital Pharmacists (EAHP) in Brussels, Belgium, presents the update on drug shortages in Germany based on the report 2020 of the German society of pharmacists.
The shortages are a major problem for more than 83% of the pharmacists who also need 10% of their work time to solve the problems
Subscribe to our blog for regular up to date posts
Marianne Hald Clemmensen, Pharmacist, PhD, Head of Medicines Information at the Hospital Pharmacy, Capital Region of Denmark presents the update on drug shortages situation in Denmark
Leonidas Tzimis, Hospital Pharmacist, Head of the Pharmacy Department at the "Saint George" Chania General Hospital in Chania, Greece, presents the update on drug shortages in Greece. The problem of medicines shortages in Greece is similar to the pan-European shortage, as in almost all countries of the European Union (EU)
Panagiotis Petrou, Visiting Lecturer in Pharmacoepidemiology and Pharmacovigilance from the University of Nicosia, Nicosia, Cyprus presents the update on drug shortages situation in Cyprus
Vesna Vujic Aleksic, MD, clinical pharmacologist from the RS Agency for Certification, Accreditation and Quality Improvement in Health Care, in Banja Luka, Bosnia and Herzegovina, presents the update on drug shortages in Bosnia and Herzegovina. Only manufacturers are obliged to notify the Agency for Medicinal Products and Medical Devices of Bosnia and Herzegovina about their decision to discontinue the manufacturing or marketing of a medicinal product prior to the expiry of the marketing authorization
Erin R. Fox, PharmD, Senior Pharmacy Director, University of Utah Health. This presentation summarizes the current state of drug shortages in the US as well as recent actions to mitigate the problem. Recent FDA actions, legislation, and ongoing actions are discussed
Helena Baptista, researcher at the NOVA Information Management School in Lisboa and Joao Miranda, researcher at the Portalegre Polytechnics Institute in Portalegre, Portugal, present a brief overview research project to understand the role of price in medicines shortage
Monika Derecque-Pois, Director General, GIRP - the European Healthcare Distribution Association, Belgium, presents the findings of a study, carried out by her association, comparing the root causes of shortages, published by the websites of national medicines agencies
Members of the Information Commissioner’s Office (ICO) Registration No: ZB231371
Registered address: Windsor House, Cornwall Rd, Harrogate HG1 2PW
Trading address: Binley Business Park, Harry Weston Road, Binley, Coventry, England, CV3 2TX
Copyright © 2021 iEthico - All Rights Reserved